share_log

泽璟制药(688266.SH):重组人凝血酶纳入2024年国家医保药品目录

Zejing Pharmaceutical (688266.SH): Recombinant human thrombin included in the National Medical Insurance Pharmaceutical Directory for 2024.

Gelonghui Finance ·  Nov 28, 2024 16:42

On November 28th, Ge Longhui reported that Zejing Pharmaceutical (688266.SH) announced that the National Healthcare Security Administration, Ministry of Human Resources and Social Security released the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (2024)" (referred to as the "National Medical Insurance Drug List"), Suzhou Zejing Biopharmaceutical Co., Ltd.'s independently developed recombinant human coagulation factor has been included in the National Medical Insurance Drug List through national medical insurance negotiations. The 2024 National Medical Insurance Drug List will take effect on January 1, 2025.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment